TELO8® — Clinical Geroscience & The Longevity Bridge Protocol (Formulation & Pre-Seed Positioning)
Proprietary Longevity Brand
BRAND ARCHITECTURE
wellness health
DTC
Product Development
Brand Strategy
Telo8®
TELO8® — Clinical Geroscience & The Longevity Bridge Protocol (Formulation & Pre-Seed Positioning)
TELO8® is an uncompromising geroscience brand built on the Longevity Bridge Theory: providing human biology with optimal cellular defense today so individuals reach upcoming biotechnology and epigenetic breakthroughs in peak biological condition.
Venture Owner
SAS ROOTS REMEDYS
Released
Timeframe
3 months
Asset Type
Proprietary Longevity Brand
Technology
The Longevity Bridge Strategy · Pharmacokinetic Dual-Step Delivery · UKIPO Class 5 Strategy
Telo8®
Overview
The protocol addresses foundational cellular aging mechanisms—telomere integrity, mitochondrial ATP bioenergetics, and autophagy—engineered as a high-adherence daily ritual for long-term healthspan extension.
TELO8® is an uncompromising geroscience brand built around a targeted dual-delivery system engineered to optimize human healthspan and chromosome integrity. Rather than selling bloated, all-in-one wellness drinks or over-promising unproven instant age reversal, TELO8® delivers targeted cellular defense.
Telo8®
The Challenge
The longevity sector is saturated with two extremes: overhyped brands promising miraculous age reversal with weak human evidence, and bloated "90-in-1" daily powders that micro-dose active compounds without biological impact.
Conventional supplement formulations attempt to combine water-soluble and lipid-soluble bioactives into single drink mixes, compromising the absorption of essential lipophilic compounds like CoQ10 and polyphenols. Consumers face expensive, unscientific routines and pill fatigue from 15-bottle stacks.
Telo8®
The Solution
TELO8® solves bioavailability limits and consumer fatigue through a structured 2-Step Daily Cellular System: STEP 01 (Daily Cellular Sachet) delivers water-soluble NAD+ precursors, Spermidine for autophagy clearance, and chromosome-protecting adaptogens in an osmotic hydration base.
The Longevity Bridge Strategy · Pharmacokinetic Dual-Step Delivery · UKIPO Class 5 Strategy
STEP 02 (Mitochondrial Softgel) is a precision lipid-carrier softgel engineered to maximize the absorption of fat-soluble mitochondrial drivers, including Urolithin A for mitophagy activation, CoQ10, and membrane-protective phospholipids.
Telo8®
Telo8®
Performance Results
TELO8® establishes an authoritative geroscience benchmark by translating complex molecular biology into a minimalist, high-adherence consumer ritual. Built for international DTC subscription retention, the brand is anchored by the exact 5-letter global domain telo8.com and insulated under French IP holding SAS Roots Remedys.
Delivery Steps
Dual-Step Pharmacokinetic System
Cellular Targets
Telomeres, Mitophagy & NAD+
Exact Match Domain & Vault
Exact Match Domain & Vault
The decoupled visual architecture—combining a clinical wordmark with an iconic rotated infinity loop emblem—provides strong differentiation across matte-black apothecary packaging and digital touchpoints, positioning TELO8® as an enduring bridge to future longevity therapeutics.
Telo8®
Final thoughts
Positioned as an enduring platform for clinical longevity, maintaining cellular integrity today to bridge the gap to the biotechnology breakthroughs of tomorrow.
Telo8®
Credits
SAS Roots Remedys
APG Brand Studio
Cellular Longevity Labs
UKIPO Class 5 Strategy
Venture Owner & IP Vault
Formulation Studio & Brand Architecture
Scientific Research & Development
Regulatory & Trademark Framework
Previous Venture
TELO8® — Clinical Geroscience & The Longevity Bridge Protocol (Formulation & Pre-Seed Positioning)
Proprietary Longevity Brand
BRAND ARCHITECTURE
wellness health
DTC
Product Development
Brand Strategy
Telo8®
TELO8® — Clinical Geroscience & The Longevity Bridge Protocol (Formulation & Pre-Seed Positioning)
TELO8® is an uncompromising geroscience brand built on the Longevity Bridge Theory: providing human biology with optimal cellular defense today so individuals reach upcoming biotechnology and epigenetic breakthroughs in peak biological condition.
Venture Owner
SAS ROOTS REMEDYS
Released
Timeframe
3 months
Asset Type
Proprietary Longevity Brand
Technology
The Longevity Bridge Strategy · Pharmacokinetic Dual-Step Delivery · UKIPO Class 5 Strategy
Telo8®
Overview
The protocol addresses foundational cellular aging mechanisms—telomere integrity, mitochondrial ATP bioenergetics, and autophagy—engineered as a high-adherence daily ritual for long-term healthspan extension.
TELO8® is an uncompromising geroscience brand built around a targeted dual-delivery system engineered to optimize human healthspan and chromosome integrity. Rather than selling bloated, all-in-one wellness drinks or over-promising unproven instant age reversal, TELO8® delivers targeted cellular defense.
Telo8®
The Challenge
The longevity sector is saturated with two extremes: overhyped brands promising miraculous age reversal with weak human evidence, and bloated "90-in-1" daily powders that micro-dose active compounds without biological impact.
Conventional supplement formulations attempt to combine water-soluble and lipid-soluble bioactives into single drink mixes, compromising the absorption of essential lipophilic compounds like CoQ10 and polyphenols. Consumers face expensive, unscientific routines and pill fatigue from 15-bottle stacks.
Telo8®
The Solution
TELO8® solves bioavailability limits and consumer fatigue through a structured 2-Step Daily Cellular System: STEP 01 (Daily Cellular Sachet) delivers water-soluble NAD+ precursors, Spermidine for autophagy clearance, and chromosome-protecting adaptogens in an osmotic hydration base.
The Longevity Bridge Strategy · Pharmacokinetic Dual-Step Delivery · UKIPO Class 5 Strategy
STEP 02 (Mitochondrial Softgel) is a precision lipid-carrier softgel engineered to maximize the absorption of fat-soluble mitochondrial drivers, including Urolithin A for mitophagy activation, CoQ10, and membrane-protective phospholipids.
Telo8®
Telo8®
Performance Results
TELO8® establishes an authoritative geroscience benchmark by translating complex molecular biology into a minimalist, high-adherence consumer ritual. Built for international DTC subscription retention, the brand is anchored by the exact 5-letter global domain telo8.com and insulated under French IP holding SAS Roots Remedys.
Delivery Steps
Dual-Step Pharmacokinetic System
Cellular Targets
Telomeres, Mitophagy & NAD+
Exact Match Domain & Vault
Exact Match Domain & Vault
The decoupled visual architecture—combining a clinical wordmark with an iconic rotated infinity loop emblem—provides strong differentiation across matte-black apothecary packaging and digital touchpoints, positioning TELO8® as an enduring bridge to future longevity therapeutics.
Telo8®
Final thoughts
Positioned as an enduring platform for clinical longevity, maintaining cellular integrity today to bridge the gap to the biotechnology breakthroughs of tomorrow.
Telo8®
SAS Roots Remedys
APG Brand Studio
Cellular Longevity Labs
UKIPO Class 5 Strategy
Venture Owner & IP Vault
Formulation Studio & Brand Architecture
Scientific Research & Development
Regulatory & Trademark Framework
Previous Venture
TELO8® — Clinical Geroscience & The Longevity Bridge Protocol (Formulation & Pre-Seed Positioning)
Proprietary Longevity Brand
BRAND ARCHITECTURE
wellness health
DTC
Product Development
Brand Strategy
Telo8®
TELO8® — Clinical Geroscience & The Longevity Bridge Protocol (Formulation & Pre-Seed Positioning)
TELO8® is an uncompromising geroscience brand built on the Longevity Bridge Theory: providing human biology with optimal cellular defense today so individuals reach upcoming biotechnology and epigenetic breakthroughs in peak biological condition.
Venture Owner
SAS ROOTS REMEDYS
Released
Timeframe
3 months
Asset Type
Proprietary Longevity Brand
Technology
The Longevity Bridge Strategy · Pharmacokinetic Dual-Step Delivery · UKIPO Class 5 Strategy
Telo8®
Overview
The protocol addresses foundational cellular aging mechanisms—telomere integrity, mitochondrial ATP bioenergetics, and autophagy—engineered as a high-adherence daily ritual for long-term healthspan extension.
TELO8® is an uncompromising geroscience brand built around a targeted dual-delivery system engineered to optimize human healthspan and chromosome integrity. Rather than selling bloated, all-in-one wellness drinks or over-promising unproven instant age reversal, TELO8® delivers targeted cellular defense.
Telo8®
The Challenge
The longevity sector is saturated with two extremes: overhyped brands promising miraculous age reversal with weak human evidence, and bloated "90-in-1" daily powders that micro-dose active compounds without biological impact.
Conventional supplement formulations attempt to combine water-soluble and lipid-soluble bioactives into single drink mixes, compromising the absorption of essential lipophilic compounds like CoQ10 and polyphenols. Consumers face expensive, unscientific routines and pill fatigue from 15-bottle stacks.
Telo8®
The Solution
TELO8® solves bioavailability limits and consumer fatigue through a structured 2-Step Daily Cellular System: STEP 01 (Daily Cellular Sachet) delivers water-soluble NAD+ precursors, Spermidine for autophagy clearance, and chromosome-protecting adaptogens in an osmotic hydration base.
The Longevity Bridge Strategy · Pharmacokinetic Dual-Step Delivery · UKIPO Class 5 Strategy
STEP 02 (Mitochondrial Softgel) is a precision lipid-carrier softgel engineered to maximize the absorption of fat-soluble mitochondrial drivers, including Urolithin A for mitophagy activation, CoQ10, and membrane-protective phospholipids.
Telo8®
Telo8®
Performance Results
TELO8® establishes an authoritative geroscience benchmark by translating complex molecular biology into a minimalist, high-adherence consumer ritual. Built for international DTC subscription retention, the brand is anchored by the exact 5-letter global domain telo8.com and insulated under French IP holding SAS Roots Remedys.
Delivery Steps
Dual-Step Pharmacokinetic System
Cellular Targets
Telomeres, Mitophagy & NAD+
Exact Match Domain & Vault
Exact Match Domain & Vault
The decoupled visual architecture—combining a clinical wordmark with an iconic rotated infinity loop emblem—provides strong differentiation across matte-black apothecary packaging and digital touchpoints, positioning TELO8® as an enduring bridge to future longevity therapeutics.
Telo8®
Final thoughts
Positioned as an enduring platform for clinical longevity, maintaining cellular integrity today to bridge the gap to the biotechnology breakthroughs of tomorrow.
Telo8®
SAS Roots Remedys
APG Brand Studio
Cellular Longevity Labs
UKIPO Class 5 Strategy
Venture Owner & IP Vault
Formulation Studio & Brand Architecture
Scientific Research & Development
Regulatory & Trademark Framework
Previous Venture
APG BRAND VENTURE STUDIO
For syndicate, SEIS/EIS, and strategic funding inquiries, contact the studio directly.
Meet the partners who are part of our success story
APG BRAND VENTURE STUDIO
For syndicate, SEIS/EIS, and strategic funding inquiries, contact the studio directly.
Meet the partners who are part of our success story
APG BRAND VENTURE STUDIO
For syndicate, SEIS/EIS, and strategic funding inquiries, contact the studio directly.
Meet the partners who are part of our success story